AAN presents ethical considerations relating to dementia care
Jul 13, 2021
Timely anticipatory planning in early dementia is crucial to preserve autonomy over future decisions and to reduce caregiver strain.
Donanemab slows clinical progression in early Alzheimer’s disease
Jul 17, 2023
The drug slows clinical progression at 76 weeks for those with low/medium tau and the combined low/medium and high tau pathology population.
5 lessons we’ve learned by not segregating memory care residents
By
Vassar Byrd
Feb 03, 2020
The benefits of not offering memory care in a separate, locked unit far outweigh the effort needed — and we’ve learned some lessons along the way.
It’s a good time for a move to senior living, data show
By
Lois A. Bowers
Apr 20, 2016
Annual senior living costs increased 2.7% from 2014 to 2016, according to new data released by senior living referral service A Place for Mom. The increase outpaces inflation but still beats the housing...
AAN: Higher scores on life’s simple 7 linked to lower dementia risk in women
Mar 01, 2023
For women, a higher AHA Life’s Simple 7 score at baseline in midlife is linked to a reduced risk for later-life dementia.
When it comes to virtual reality, imagination often trumps innovation, research finds
By
Aaron Dorman
Aug 28, 2023
When it comes to virtual reality, programming advances in the tech may not be as important to users as what they bring themselves: their imagination.
Alzheimer’s in danger of straining public funding: report
By
Lois A. Bowers
Oct 05, 2017
Social and demographic trends combined with an expected increase in the incidence of Alzheimer’s diseases due to the growing size of the aging population are in danger of colliding to strain local,...
Digital health summit recognizes ‘breakthrough’ winners for key innovations
By
Aaron Dorman
Jul 11, 2023
Recent winners of HITLAB’s Innovators Challenge include a virtual care program for chronic inflammation and a dance-pairing startup.
ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.